Dr. René Rizzoli is an internist and endocrinologist, with a subspecialty focus on metabolic bone diseases, osteoroposis and disorders of mineral metabolism.

He is involved in both basic and clinical research projects investigating hormone action, regulation of bone growth, regulation of mineral homeostasis, pathophysiology of osteoroposis and the role of nutrition, calcium, vitamin D, bisphosphonates, selective estrogen modulators denosumab, teriparatide and strontium ranelate in the prevention and treatment of osteoroposis. Dr. Rizzoli is author of more than 550 scientific articles. He is Editor of Bone and Associate Editor of Osteoroposis International.